The Connecticut House of Representatives has passed legislation to remove THC concentration limits on cannabis flower and raise limits for infused beverages, aiming to make the state's legal market more competitive with neighboring states.
- Eliminated Caps: The bill removes existing THC limits on cannabis flower, plant material, and concentrates.
- Beverage Increases: THC allowances in standard infused drinks will rise from 3mg to 5mg, with dispensary products allowed up to 10mg.
- Economic vs. Health Debate: Proponents argue the changes are necessary for business survival, while opponents cite severe concerns regarding youth mental health and addiction.
- Operational Shifts: The legislation reduces mandatory on-site pharmacist hours at dispensaries and expands the types of products available.
The Connecticut House of Representatives passed a contentious bill Monday night designed to overhaul the state's recreational cannabis market. Driven by a push to remain economically competitive, the legislation eliminates THC concentration caps on cannabis flower and modifies operational regulations for dispensaries.
Since narrowly legalizing recreational cannabis in 2021, Connecticut lawmakers have continuously debated market parameters. Proponents of the new bill argue that current restrictions place local businesses at a severe disadvantage compared to markets in New York, Massachusetts, and Rhode Island.
Rep. Roland Lemar stated that the legislation modernizes laws to reflect market realities, arguing that restrictive regulations have stifled business potential and investment in the state.
To address these market barriers, the bill introduces several key regulatory shifts:
| Regulatory Area | Previous/Current Standard | Proposed Changes Under New Bill |
|---|---|---|
| Cannabis Flower & Concentrates | Capped THC concentration | THC limits eliminated |
| Infused Drinks (General Retail) | 3 mg THC limit | 5 mg THC limit |
| Infused Drinks (Dispensaries) | N/A | Up to 10 mg THC limit |
| Pharmacist Oversight | Standard on-site requirements | 8 hours/week on-site; 35 hours/week via video |
However, the removal of THC caps faced intense pushback from lawmakers prioritizing public health. Opponents argued that higher concentrations of THC increase the risk of addiction and psychosis, particularly among young users.
Rep. David Rutigliano highlighted warnings from medical professionals who explicitly advised against raising THC limits. House Minority Leader Vincent Candelora echoed these concerns, noting that the state's healthcare infrastructure lacks the capacity to treat an increase in marijuana-induced psychiatric conditions.
During the debate, Rep. Tom O’Dea cited a Massachusetts General Hospital study indicating that teenage psychiatric emergency room visits quadrupled following the state's legalization of recreational marijuana.
In response to health concerns, proponents argued that the legal, regulated market is not the primary driver of youth overdoses. Lemar contended that allowing dispensaries to sell higher-potency, tested products will naturally draw consumers away from dangerous, unregulated products sold illegally at gas stations and bodegas.
Beyond potency limits, the bill expands the legal marketplace to include topicals, tablets, and capsules, and permits out-of-state patients to purchase medical cannabis. This expansion also drew criticism regarding patient safety.
Rep. Tracy Marra objected to provisions reducing the required on-site hours for licensed pharmacists. She argued that vulnerable medical patients rely heavily on pharmacists to identify potentially dangerous drug interactions, a role that goes beyond simply dispensing products.
